NVAX 主要統計
高い
8.13
オープン
7.91
取引高
2.53M
低い
7.87
前日終値
7.88
売買代金
20.33M
52週高値
11.97
相対取引高
0.653
変動幅 (%)
3.30%
52週安値
6.20
売買回転率
1.54%
時価総額
1.29B
PER（TTM）
--
PER（年次）
2.897
PBR
-8.95
PSR
2.17
1株当たり利益（EPS）
-0.598
配当（TTM）
0
配当利回り
0.00%
発行済株式数
164.43M
通貨単位
USD
NVAX 価格パフォーマンス
7 日
30 日
90 日
180 日
年初来
1 年
NVAX マネーフロー分布
NVAX 日次空売り出来高
NVAX ショートインタレスト履歴
NVAX 株式スナップショット
As of 2026-07-22, the Novavax, Inc. (NVAX) stock price today is 8.075. Based on this price, the company has a market capitalization of $1.29B, with a P/E ratio of --.
On 2026-07-22, NVAX traded between 7.87 and 8.13. Today’s stock price is 2.60% above the daily low and 0.68% below the daily high, placing NVAX 高めの範囲に its most recent trading range.
Trading volume currently stands at 2.53M, compared with an average daily volume of 3.87M. This suggests that trading activity is 通常水準を下回る than usual.
Over the past year, Novavax, Inc. shares have traded between 6.20 and 11.97. At today’s price, NVAX is 30.24% above its 52-week low and 32.54% below its 52-week high.
NVAX 関連ニュース
について NVAX
企業名
Novavax, Inc.
セクター
Health Technology
業種
Biotechnology
取引所
Nasdaq
従業員数
749
ロットサイズ
100
公式サイト
通貨単位
USD
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Related Stocks
